Atlas FDA

GORE® VIABAHN® Endoprosthesis and GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface

FDA premarket approval P130006/S087 · decided 2022-01-28

Approval details

PMA number
P130006
Supplement
S087
Supplement type
Real-Time Process
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
GORE® VIABAHN® Endoprosthesis and GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface
Generic name
System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment
Applicant
W. L. Gore & Associates, Inc.
Date received
2021-10-25
Decision date
2022-01-28
Days to decision
95 days
Decision code
APPR
Product code
PFV
Advisory committee
Cardiovascular
Expedited review
No
Location
Flagstaff, AZ
Statement
Approval for minor labeling changes.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
GORE® Tri-Lobe Balloon Catheter (K250410)W. L. Gore & Associates, Inc.2025-06-02
GORE® PROPATEN® Vascular Graft (K240083)W. L. Gore & Associates, Inc.2024-03-01
GORE® PROPATEN® Vascular Graft (K232312)W. L. Gore & Associates, Inc.2024-01-09
GORE® ACUSEAL Vascular Graft (K233551)W. L. Gore & Associates, Inc.2023-12-19
GORE® ACUSEAL Vascular Graft (K231505)W. L. Gore & Associates, Inc.2023-06-23
GORE BIO-A Tissue Reinforcement (K191773)W. L. Gore & Associates, Inc.2019-07-31
GORE SEAMGUARD Bioabsorbable Staple Line Reinforcement (K181940)W. L. Gore & Associates, Inc.2018-08-17
GORE ENFORM Biomaterial (K173333)W. L. Gore & Associates, Inc.2018-04-05